An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer

Surgery

Volumn 142, Issue 5, 2007, Pages 741-748

  Isogai, Akiko ^a   Nagaya, Masaki ^a   Matsuoka, Hiromitsu ^a   Watanabe, Taiji ^a   Tsukikawa, Satoshi ^a   Kubota, Sunao ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPYRIMIDINE; FLUOROURACIL; UFT;

ADJUVANT THERAPY; ADULT; AGED; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALAISE; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG COMBINATIONS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; SURVIVAL RATE; TEGAFUR; URACIL;

EID: 35548961301     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.06.017     Document Type: Article

References (32)

1. Francini G., Petrioli R., Lorenzini L., Mancini S., Armenio S., Tanzini G., et al. Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106 (1994) 899-906
2. IMPACT. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345 (1995) 939-944
3. O'Connel M.J., Laurie J.A., Kahn M., Fitzgibbons Jr. R.J., Erlichman C., Shepherd L., et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 16 (1998) 295-300
4. Kodaira S., Kikuchi K., Yasutomi M., Takahashi T., Hojo K., and Kato T. Postoperative adjuvant chemotherapy with mitomycin C and UFT for curative resected rectal cancer. Results from the cooperative project No.7 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer. Int J Clin Oncol 3 (1998) 357-364
5. Kato T., Ohashi Y., Nakazato H., Koike A., Saji S., and Suzuki H. Efficacy of oral UFT as adjuvant chemotherapy curative resection of colorectal cancer: Multicentre prospective randomized trial. Langenbeck's Arch Surg 386 (2002) 575-581
6. Pazdur R., Lassere Y., Rhodes V., Ajani J.A., Sugarman S.M., Patt Y.Z., et al. Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 12 (1994) 2296-2300
7. Saltz L.B., Leichman C.G., Young C.W., Muggia F.M., Conti J.A., Spiess T., et al. A fixed-ratio combination of uracil and tegafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer. Cancer 75 (1995) 782-785
8. Kondo T., Imamura T., and Ichihashi H. In vitro test for sensitivity of tumor to carcinostatic agents. Gann 57 (1966) 113-121
9. Salmon S.E. Human tumor colony assay and chemosensitivity testing. Cancer Treat Rep 68 (1984) 117-125
10. Vescio R.A., Redfern C.H., Nelson T.J., Ugortz S., Stern P.H., and Hoffman R.M. In vitro-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Pro Natl Acad Sci USA 84 (1987) 5029-5033
11. Suto A., Kubota T., Shimoyama Y., Isibiki K., and Abe O. MTT assay with reference to the clinical effect of chemotherapy. J Surg Oncol 42 (1989) 28-32
12. Schrag D., Garewal H.S., Burstein H.J., Samson D.J., VonHoff D.D., and Somerfield M.R. American society of clinical oncology technology assessment: Chemosensitivity and resistance assays. J Clin Oncol 22 (2004) 3631-3638
13. Matsuoka H. A new method of three-dimensional chemosesivitivity test using thermoreversible gelation polymer (TGP) as culture material (in Japanese). St Marianna Med J 27 (1999) 411-418
14. Yoshikawa T., and Tsukikawa S. Chemosenstivity test of human cancer cell lines in three-dimensional culture using thermoreversible gelation polymer(in Japanese). St Marianna Med J 28 (2000) 477-486
15. Matsuoka H., Nagaya M., Tsukikawa S., Yanagi Y., Isogai A., and Kubota S. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer. Surgery 140 (2006) 387-395
16. Japanese Research Society for Cancer of Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. 6th ed. (1998), Kanehara & Co, Japan
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
18. Carmichael J., DeGraff W.G., and Gazdar A.F. Evaluation a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47 (1987) 936-942
19. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., and Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19 (1996) 1518-1520
20. Takamatsu N. The new colorimetric assay (WST-8) for cellular growth with aging and Alzheimer's disease. Nippon Ronen Igakkai Zasshi 35 (1998) 535-542
21. Japan Society for Cancer Therapy. Criteria for the evaluation of the clinical effects of solid cancer chemotherapy. J Jpn Soc Cancer Ther 28 (1993) 101-130
22. Japanese Society for Cancer of Colon and Rectum. Guide-line for treatment of colorectal cancer (2005), Kanehara & Co, Japan
23. Sadahiro S., Mitomi T., Noto T., Kumada K., Hiki Y., and Yamakawa T. Multicenter comparative study of the recurrence inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection(in Japanese). Jpn J Cancer Chemother 32 (2005) 997-1005
24. Ohwada S., Ikeya T., Yokomori T., Kusaba T., Roppongi T., Takahashi T., et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: A randomized controlled study. Br J Cancer 90 (2004) 1003-1010
25. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10 (1992) 896-903
26. Seifert P., Baker L.H., Reed M.L., and Vaitkevicius V.K. Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer 36 (1975) 123-128
27. Lokich J.J., Ahlgren J.D., Gullo J.J., Philips J.A., and Fryer J.G. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. J Clin Oncol 7 (1989) 425-432
28. Leichman C.G., Fleming T.R., Muggia F.M., Tangen C.M., Ardalan B., Doroshow J.H., et al. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: A Southwest Oncology Group study. J Clin Oncol 13 (1995) 1303-1311
29. Chang A.E., Schneider P.D., Sugarbaker P.H., Simpson C., Culnane M., and Steinberg S.M. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206 (1987) 685-693
30. Hohn D.C., Stagg R.J., Friedman M.A., Hannigan Jr. J.F., Rayner A., Ignoffo R.J., et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxyuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 7 (1989) 1646-1654
31. Rougier P., Laplanche A., Huguier M., Hay J.M., Ollivier J.M., Escat J., et al. Hepatic arterial infusion of floxyuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10 (1992) 1112-1118
32. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88 (1996) 252-258